The Challenge Treatment of Medication Related Osteonecrosis of the Jaw : A Case Report

@inproceedings{Sanchez2015TheCT,
  title={The Challenge Treatment of Medication Related Osteonecrosis of the Jaw : A Case Report},
  author={R. Sanchez and A Bassi and Pedro Carvalho},
  year={2015}
}
Bisphosphonates (BP) are broadly used for metabolic bone disorders and bone metastasis treatment [1-4]. Medication related osteonecrosis of the jaw (MRONJ) is a known side effect of bisphosphonates use and other antiresorptive or antiangiogenic agents [5, 6]. Osteonecrosis of the jaw developed for BP represents an estimate prevalence of 0.10% related to… CONTINUE READING